Gentherapeutische Strategien gegen das kolorektale Karzinom

Gentherapie - kolorektales Karzinom - Immuntherapie - Stammzelltherapie

Gene therapy - colorectal cancer - immune therapy - stem cell therapy

Literatur

• 1 Weitz J, Koch M, Debus J, Hohler T, Galle P R, Buchler M W. Colorectal cancer.  Lancet. 2005;  365 153-365
• 2 Venook A. Critical evaluation of current treatments in metastatic colorectal cancer.  Oncologist. 2005;  10 250-261
• 3 Zwacka R M, Dunlop M G. Gene therapy for colon cancer.  Hematol Oncol Clin North Am. 1998;  12 595-615
• 4 Cross D, Burmester J K. Gene therapy for cancer treatment: past, present and future.  Clin Med Res. 2006;  4 218-227
• 5 Bischoff J R, Kirn D H, Williams A. et al . An adenovirus mutant that replicates selectively in p53-deficient human tumor cells.  Science. 1996;  274 373-376
• 6 Li C, Bowles D E, Dyke van T, Samulski R J. Adeno-associated virus vectors: potential applications for cancer gene therapy.  Cancer Gene Ther. 2005;  12 913-925
• 7 Mohr A, Henderson G, Dudus L, Herr I, Kuerschner T, Debatin K M, Weiher H, Fisher K J, Zwacka R M. AAV-encoded expression of TRAIL in experimental human colorectal cancer leads to tumor regression.  Gene Ther. 2004;  11 534-543
• 8 Glick R P, Lichtor T, Cohen E P. Cytokine immunogene therapy.  Neurosurg Focus. 2000;  9 e2
• 9 Morgan R A, Dudley M E, Wunderlich J R. et al . Cancer regression in patients after transfer of genetically engineered lymphocytes.  Science. 2006;  314 126-129
• 10 Studeny M, Marini F C, Champlin R E, Zompetta C, Fidler I J, Andreeff M. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors.  Cancer Res. 2002;  62 3603-3608